Kyowa Kirin Shares Rise After Joining U.S. Drug-Pricing Agreement
Kyowa Kirin's shares climbed after the company joined eight other drugmakers in a U.S. pricing agreement announced by the Trump administration. The pact, which requires participating firms to reduce prices for medicines in the U.S. Medicaid program, coincided with the company reaffirming a positive tone after reporting favorable results for the Jan…